Chris Beyrer, MD, MPH, a longtime faculty member at the Johns Hopkins Bloomberg School of Public Health, globally recognized AIDS researcher and advocate, and former president of the International AIDS Society (IAS), is among five finalists to lead the Joint United Nations Programme on HIV/AIDS.
For the first time researchers have been able to completely eliminate HIV from a mouse model. It marks a critical step toward the development of a possible cure for human HIV infection.
Below are summaries of recent Fred Hutch research, with links for additional background and media contacts.
When people suffer from both HIV and TB, it creates “one of the biggest health problems in the world,” according to Texas Biomed Assistant Professor Smita Kulkarni, Ph.D. Now, the National Institutes of Health is funding a two-year study by Texas Biomed scientists developing a lab model that mimics the early stages of the co-infection of these two diseases.
Northeast Ohio philanthropist Roe Green has added $9 million to her original gift of $5 million from 2014 to the travel medicine and global health center named for her at University Hospitals based in Cleveland.
Scientists have taken a common, yet laborious lab test and redesigned it to be performed in small 3D printed pipette tips used to measure and transfer fluids in the laboratory.
HIV testing is expensive ($50 to $200 per test), technically complex, and requires trained technicians. Researchers are developing a rapid, disposable, automated, and low-cost HIV viral load assay to increase timely access to HIV care and to improve treatment outcomes. The technology is highly sensitive, inexpensive (less than $1), and quick (results in 45 minutes or less). Moreover, the technology is highly stable, and doesn’t require refrigeration or a regular electric supply to enable HIV viral load at point-of-care settings.
New testing methods being developed by Molecular Testing Labs and Boise State University utilize RNA molecular signatures, which can be detected using cutting edge technology and lab techniques. This means that people at risk for contracting HIV can get tested much earlier than current methods – typically within the same week as the potential exposure.
Nurse practitioners are more likely to conduct HIV screenings if they feel that their colleagues support routine screenings, according to new research from Binghamton University, State University of New York. This comes in advance of National HIV Testing Day, taking place June 27.
Perry N. Halkitis, the author Out in Time: From Stonewall to Queer, How Gay Men Came of Age Across the Generations, addresses how Stonewall and the AIDS crisis have brought awareness and changes the ways the medical profession addresses health care of LGBTQ people.
Duke researchers describe a previously unidentified route for antibodies to be transferred from the mother to the fetus, illuminating a potential way to capitalize on this process to control when and how certain antibodies are shared.
The National Institutes of Health (NIH) has awarded a seven-year, $23 million grant to researchers at Albert Einstein College of Medicine and Montefiore Health System to study HIV and the chronic illnesses that often accompany HIV infection, including cardiovascular and lung disease, diabetes, and cancer.
Sanjay B. Maggirwar, PhD, MBA, has been selected to serve as chair of the Department of Microbiology, Immunology, and Tropical Medicine at the George Washington University School of Medicine and Health Sciences
The Department of Health and Human Services’ announcement Wednesday that it will halt funding for research involving the use of human fetal tissue conducted within the National Institutes of Health
Every day, there are more than 1 million new cases of curable sexually transmitted infections (STIs) among people aged 15-49 years, according to data released today by the World Health Organization.
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with the immunotherapy drug pembrolizumab, also known by its brand name, KEYTRUDA®.
Scientists at Fred Hutchinson Cancer Research Center took a step toward making gene therapy more practical by simplifying the way gene-editing instructions are delivered to cells. Using a gold nanoparticle instead of an inactivated virus, they safely delivered gene-editing tools in lab models of HIV and inherited blood disorders, as reported May 27 in Nature Materials.
Allowing Discrimination, Administration Proposals Threaten Transgender Health and Progress Against HIV Epidemic
According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at suppressing the virus, but facts gathered on the ground show that many struggle with issues of daily living that can make taking a pill to keep HIV at bay difficult.
A new HIV vaccine delivery strategy appears to enhance the protective immune response in a preclinical model. Scientists at the La Jolla Institute for Immunology (LJI) have discovered that delivering an HIV vaccine in small doses over a series of days leads to a stronger immune response than when the same vaccine is given all at once.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right